Strides Pharma Science Ltd. - Research Center
532531 STAR Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 1,854.50 | 1,979.00 | 1,857.57 | 1,674.15 | 1,537.44 |
| Operating profit | 98.48 | 76.63 | 187.32 | 210.04 | 139.03 |
| Interest | 138.68 | 74.24 | 65.34 | 66.71 | 54.09 |
| Gross profit | 43.86 | 125.87 | 210.98 | 243.49 | 199.55 |
| EPS (Rs) | 0.52 | 20.07 | 8.72 | 12.47 | 12.32 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 84.07 | 123.49 | 89.00 | 100.16 | 114.61 |
| Stock adjustment | 21.04 | 114.26 | -117.53 | 1.18 | -45.52 |
| Raw material | 1,020.10 | 935.42 | 1,050.10 | 848.34 | 903.77 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 267.01 | 272.09 | 272.72 | 221.77 | 223.21 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 447.87 | 580.60 | 464.96 | 392.82 | 316.95 |
| Provisions made | - | - | - | - | - |
| Depreciation | 93.62 | 104.37 | 99.34 | 91.63 | 83.00 |
| Taxation | -69.44 | -158.68 | 33.40 | 40.16 | -1.38 |
| Net profit / loss | 4.68 | 180.19 | 78.24 | 111.70 | 110.37 |
| Extra ordinary item | -15.00 | - | - | - | -7.56 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 90.30 | 89.79 | 89.68 | 89.55 | 89.55 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 5.31 | 3.87 | 10.08 | 12.55 | 9.04 |
| GPM (%) | 2.26 | 5.99 | 10.84 | 13.72 | 12.08 |
| NPM (%) | 0.24 | 8.57 | 4.02 | 6.30 | 6.68 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis